Видео с ютуба Dabrafenib

Dr. Michael Rotkowitz on Dabrafenib and Trametinib Combination Side Effects

The success of the dabrafenib and trametinib combination in BRAF-mutated melanoma

Adverse Events With Dabrafenib/Trametinib Combination in Melanoma

5-year follow-up: dabrafenib plus trametinib reduces relapse risk in melanoma

Dr. Michael Rotkowitz on the Dabrafenib Plus Trametinib Combination for Melanoma

Dabrafenib Plus Trametinib Demonstrates Benefit in BRAF-Mutant Melanoma

Dr. Long on Dabrafenib/Trametinib in BRAF V600E-Mutant Melanoma

Georgina Long on Treating Melanoma With Dabrafenib Plus Trametinib

Dabrafenib, trametinib & neoadjuvant pembrolizumab in anaplastic thyroid cancer

Phase III COMBI-d Study of Dabrafenib and Trametinib in Patients With Melanoma

Dabrafenib and Trametinib in BRAF-Mutated NSCLC

Dr. Nathan on Long-Term Outcomes With Dabrafenib/Trametinib in BRAF V600-Mutant Melanoma

Updates from COMBI-AD: dabrafenib and trametinib for melanoma

Dr. Planchard on Dabrafenib/Trametinib Combo in Advanced NSCLC

Dabrafenib and trametinib: a promising combination for the treatment of melanoma

Dabrafenib plus trametinib preferable to vemurafenib alone in melanoma

Dr. Daud on Dabrafenib/Trametinib Vs Immunotherapy in Melanoma

Dr. Algazi on Benefit of Continuous Dabrafenib/Trametinib Dosing in BRAF+ Melanoma

Dr. Robert on 5-Year Analysis of Dabrafenib/Trametinib in BRAF V600-Mutant Melanoma

Continuous vs intermittent dosing of dabrafenib and trametinib in BRAF mutated melanoma